Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES. DIMETHYL FUMARATE delayed-release capsules, for oral use Initial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- dimethyl fumarate
- product_names
- Dimethyl fumarate
- ndc
- 16729-416, 16729-417, 16729-418, 16729-418-12, 16729-416-54, 16729-417-46, 16729-416-04, 16729-416-16, 16729-417-27, 16729-417-12, 16729-417-59, 16729-417-16
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en